4//SEC Filing
Yerace Daniel Alexander 4
Accession 0001683168-25-001394
CIK 0001759186other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:29 PM ET
Size
6.0 KB
Accession
0001683168-25-001394
Insider Transaction Report
Form 4
Yerace Daniel Alexander
DirectorVP of Operations
Transactions
- Award
Non-Qualified Stock Options (right to buy)
2025-03-04+5,000→ 25,000 totalExercise: $10.56→ Common Stock (1,000 underlying)
Footnotes (4)
- [F1]On March 4, 2025, the reporting person received a grant of 5,000 non-qualified stock options, under the 2022 equity incentive plan.
- [F2]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant.
- [F3]Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28.
- [F4]Expiration date is ten years from the day of grant.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001846625
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:29 PM ET
- Size
- 6.0 KB